Gou W - Search Results

1

Discovery and characterization of potent And-1 inhibitors for cancer treatment.

Li J, Zhang Y, Sun J, Chen L, Gou W, Chen CW, Zhou Y, Li Z, Chan DW, Huang R, Pei H, Zheng W, Li Y, Xia M, Zhu W. Li J, et al. Among authors: gou w. Clin Transl Med. 2021 Dec;11(12):e627. doi: 10.1002/ctm2.627. Clin Transl Med. 2021. PMID: 34923765 Free PMC article.

2

Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors.

Wei H, Duan Y, Gou W, Cui J, Ning H, Li D, Qin Y, Liu Q, Li Y. Wei H, et al. Among authors: gou w. Eur J Med Chem. 2019 Nov 1;181:111552. doi: 10.1016/j.ejmech.2019.07.055. Epub 2019 Jul 24. Eur J Med Chem. 2019. PMID: 31387063

3

Ursolic acid derivative UA232 evokes apoptosis of lung cancer cells induced by endoplasmic reticulum stress.

Gou W, Luo N, Wei H, Wu H, Yu X, Duan Y, Bi C, Ning H, Hou W, Li Y. Gou W, et al. Pharm Biol. 2020 Dec;58(1):707-715. doi: 10.1080/13880209.2020.1794013. Pharm Biol. 2020. PMID: 32726164 Free PMC article.

4

Recent progress in small-molecule inhibitors for critical therapeutic targets of necroptosis.

Fang Z, Wei H, Gou W, Chen L, Bi C, Hou W, Li Y. Fang Z, et al. Among authors: gou w. Future Med Chem. 2021 May;13(9):817-837. doi: 10.4155/fmc-2020-0386. Epub 2021 Apr 13. Future Med Chem. 2021. PMID: 33845591 Review.

5

Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2.

Yu J, Luo L, Hu T, Cui Y, Sun X, Gou W, Hou W, Li Y, Sun T. Yu J, et al. Among authors: gou w. Eur J Med Chem. 2022 Jan 5;227:113898. doi: 10.1016/j.ejmech.2021.113898. Epub 2021 Oct 9. Eur J Med Chem. 2022. PMID: 34656898

6

Discovery of novel triazole compounds as selective IL-1β releasement inhibitors.

Mu R, Zhou Y, Chen L, Wei H, Yu J, Gou W, Ye C, Hou W, Li Y, Zhu L. Mu R, et al. Among authors: gou w. Bioorg Med Chem Lett. 2021 Dec 1;53:128415. doi: 10.1016/j.bmcl.2021.128415. Epub 2021 Oct 16. Bioorg Med Chem Lett. 2021. PMID: 34662706

7

Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.

Wei H, Guo J, Sun X, Gou W, Ning H, Fang Z, Liu Q, Hou W, Li Y. Wei H, et al. Among authors: gou w. Eur J Med Chem. 2022 Jan 5;227:113918. doi: 10.1016/j.ejmech.2021.113918. Epub 2021 Oct 14. Eur J Med Chem. 2022. PMID: 34688014

8

Phosphate group functionalized magnetic metal-organic framework nanocomposite for highly efficient removal of U(VI) from aqueous solution.

Bi C, Zheng B, Yuan Y, Ning H, Gou W, Guo J, Chen L, Hou W, Li Y. Bi C, et al. Among authors: gou w. Sci Rep. 2021 Dec 21;11(1):24328. doi: 10.1038/s41598-021-03246-3. Sci Rep. 2021. PMID: 34934053 Free PMC article.

9

Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer.

Zhang Y, Wei H, Zhou Y, Li Z, Gou W, Meng Y, Zheng W, Li J, Li Y, Zhu W. Zhang Y, et al. Among authors: gou w. Clin Transl Med. 2021 Dec;11(12):e649. doi: 10.1002/ctm2.649. Clin Transl Med. 2021. PMID: 34954894 Free PMC article. No abstract available.

10

Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury.

Wei H, Gou W, Gao J, Ning H, Song Y, Li D, Qin Y, Hou W, Li Y. Wei H, et al. Among authors: gou w. Eur J Med Chem. 2022 Feb 15;230:114115. doi: 10.1016/j.ejmech.2022.114115. Epub 2022 Jan 11. Eur J Med Chem. 2022. PMID: 35033824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters